Total submissions: 23
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000036518 | SCV000110847 | benign | not specified | 2014-10-17 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000231696 | SCV000284997 | benign | Cystic fibrosis | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001027903 | SCV000466516 | likely benign | CFTR-related disorders | 2018-03-06 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. |
Center for Pediatric Genomic Medicine, |
RCV000422767 | SCV000511145 | likely benign | not provided | 2016-09-21 | criteria provided, single submitter | clinical testing | Converted during submission to Likely benign. |
Gene |
RCV000036518 | SCV000512574 | likely benign | not specified | 2017-12-26 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
ARUP Laboratories, |
RCV000422767 | SCV000602998 | likely benign | not provided | 2023-11-27 | criteria provided, single submitter | clinical testing | |
Johns Hopkins Genomics, |
RCV000231696 | SCV000886894 | likely benign | Cystic fibrosis | 2019-08-06 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000422767 | SCV000889291 | likely benign | not provided | 2022-12-19 | criteria provided, single submitter | clinical testing | |
CFTR- |
RCV000231696 | SCV001169175 | benign | Cystic fibrosis | 2018-01-29 | criteria provided, single submitter | curation | the variant does not result in CFTR-RD neither |
Ambry Genetics | RCV000231696 | SCV001172721 | benign | Cystic fibrosis | 2017-04-17 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000422767 | SCV001334750 | benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | CFTR: BP4, BS1, BS2 |
Genome- |
RCV000231696 | SCV001737309 | likely benign | Cystic fibrosis | 2021-06-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001588847 | SCV001822063 | uncertain significance | Congenital bilateral aplasia of vas deferens from CFTR mutation | 2021-07-22 | criteria provided, single submitter | clinical testing | |
Greenwood Genetic Center Diagnostic Laboratories, |
RCV000422767 | SCV002499183 | uncertain significance | not provided | 2022-01-18 | criteria provided, single submitter | clinical testing | BS2, PS3_supporting, PM3 |
Genome Diagnostics Laboratory, |
RCV000231696 | SCV002507360 | uncertain significance | Cystic fibrosis | 2020-07-23 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000119037 | SCV002529681 | benign | Hereditary pancreatitis | 2020-09-01 | criteria provided, single submitter | curation | |
Institute of Human Genetics, |
RCV000231696 | SCV002573929 | uncertain significance | Cystic fibrosis | 2022-09-05 | criteria provided, single submitter | curation | This variant was identified in 2 unrelated patients with a clinically confirmed diagnosis of cystic fibrosis. The variant was classified in the context of a project re-classifying variants in the German Cystic Fibrosis Registry (Muko.e.V.). Link: https://www.muko.info/angebote/qualitaetsmanagement/register/cf-einrichtungen/mukoweb. Criteria applied: PS3_SUP, BS1, BS2, BP7 |
Prevention |
RCV003974873 | SCV004793380 | benign | CFTR-related condition | 2019-04-01 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Laboratory for Molecular Medicine, |
RCV000036518 | SCV000060173 | not provided | not specified | 2013-09-27 | no assertion provided | clinical testing | Glu528Glu in exon 11 of CFTR (c.1584G>A, historically known as c.1716G>A): This variant has been shown to result in exon skipping in about 10% of transcripts; however, it is prevalent in many populations (highest allele frequency 6.3% in Puerto Ricans; 1000 Genomes Project; rs1800095) and therefore not expected to cause highly penetrant, Mendelian disease. Consistent with this, it has been identified in combination with a severe CF-causing variant in control populations (Rosendahl 2013). However, several studies have suggested that it may be a predisposing factor to idiopathic chronic pancreatitis, although it is unclear if this predisposition is statistically significant (Casals 2004; Rosendahl 2013; Maire 2003). In summary, this variant may be a risk factor for CF-related disease (chronic pancreatitis). It is not expected to lead to disease on its own or in combination with a pathogenic CFTR variant, but may act in conjunction with other genetic and/or environmental risk factors. |
Gene |
RCV000119037 | SCV000153743 | not provided | Hereditary pancreatitis | no assertion provided | literature only | ||
Genome |
RCV000844954 | SCV000986779 | not provided | Pancreatitis | no assertion provided | phenotyping only | Variant interpretted as Uncertain significance and reported on 02/20/2018 by GTR ID 500068. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. | |
Natera, |
RCV001027903 | SCV001190626 | likely benign | CFTR-related disorders | 2019-05-20 | no assertion criteria provided | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001027903 | SCV002507444 | uncertain significance | CFTR-related disorders | 2020-07-23 | no assertion criteria provided | clinical testing |